Licensing Deal

Alkem Looks For Partnerships In-licensing Deals To Bolster Presence In US Market

November 01,2021 10:09 AM
- By Admin

"The company would also strategically look at in-licensing opportunities, alliances and partnerships to enhance its capabilities and product portfolio, gaining further legroom for growth in the US market," Alkem Laboratories said in its Annual Report for 2020-21.

licensing deals in the US to bolster its presence in the world's largest market for pharmaceutical products. The Mumbai-based drug firm also remains positive about the company's growth prospects in the domestic market with better access to healthcare facilities and increasing penetration of medical insurance expected to act as key growth drivers. "The company would also strategically look at in-licensing opportunities, alliances and partnerships to enhance its capabilities and product portfolio, gaining further legroom for growth in the US market," Alkem Laboratories said in its Annual Report for 2020-21. Despite the continuing challenges of price deflation owing to higher competition and evolving regulatory controls, the company is positive of countering them through regular and timely new product launches, the company informed its shareholders.